There has been a series of developments recently concerning Boston Properties, Inc. (BXP). Companies such as Metis Global Partners LLC,Van ECK Associates Corp, and New York Life Investment Management LLC have made considerable acquisitions of BXP shares. On the other hand, organizations like Wedbush,StockNews.com, and Q2 2024 Earnings Forecast have downgraded BXP to 'Sell' with a lowered price target. There's a legal conflict with Brammer Bio over construction at Kendall square site, but BXP's Q1 2024 results showcased resilience, achieving Q1 FFO estimates. Furthermore, BXP has renewed its $600M ATM Offering Program and has also initiated the development of Cambridge's tallest building. BXP's Q4 FFO and revenues surpassed expectations with strong leasing. The company has seen a dynamic shift in investments and made sale of 45% interest in two key life-science assets. Despite these, the BXP stock has underperformed in the market.
Boston Properties BXP News Analytics from Sun, 17 Sep 2023 07:00:00 GMT to Tue, 07 May 2024 18:25:38 GMT -
Rating -3
- Innovation -2
- Information 7
- Rumor -1
